Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BOA Biomedical develops a proprietary blood purification device that uses nanoengineered magnetic particles to selectively remove pathogens from the bloodstream. The company also offers a digital platform for managing the entire patient journey in infectious diseases—from diagnosis through treatment tracking. Their technologies are designed to address urgent needs such as sepsis, antibiotic resistance, hospital-acquired infections, pandemic threats, and bioterrorism. They hold an exclusive global license to core technology developed at Harvard’s Wyss Institute.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BOA Biomedical.